Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
EU-Humira
BIOLOGICAL
2 trials
Sponsors
Mylan Inc.
, Fresenius Kabi SwissBioSim GmbH
Conditions
Healthy Volunteers
Moderate to Severe Rheumatoid Arthritis
Phase 1
Adalimumab PK Bioequivalence Study to EU and US Sourced Humira
Completed
NCT02472912
Mylan Inc.
Healthy Volunteers
Start: 2014-12-31
End: 2015-06-30
Updated: 2022-03-11
Phase 3
MSB11022 in Moderate to Severe Rheumatoid Arthritis
Completed
NCT03052322
Fresenius Kabi SwissBioSim GmbH
Moderate to Severe Rheumatoid Arthritis
Start: 2017-01-31
End: 2018-08-27
Updated: 2019-12-20
Related Papers
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity.
2020-12-01
34 citations
Safety of adalimumab biosimilar MSB11022 (acetate-buffered formulation) in patients with moderately-to-severely active rheumatoid arthritis.
2019-08-08
23 citations